Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL16424481 | 0.78 | MAPT (0.32) | — | |
| Hydrochloric Acid SCHEMBL4891746 | 0.77 | ALDH1A1 (0.33) | — | |
| Hydrochloric Acid SCHEMBL7753035 | 0.76 | BCHE (0.36) | — | |
| Hydrochloric Acid SCHEMBL5601720 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL7903670 | 0.73 | TSHR (0.36) | — | |
| Hydrochloric Acid SCHEMBL3661444 | 0.70 | GPR3 (0.33) | GPR3 | |
| Methane SCHEMBL5347437 | 0.69 | GPR3 (0.32) | GPR3 | |
| Hydrochloric Acid SCHEMBL5600645 | 0.69 | — | — | |
| Hydrochloric Acid SCHEMBL1116197 | 0.68 | GPR3 (0.32) | GPR3 | |
| Hydrochloric Acid SCHEMBL5089860 | 0.68 | GPR3 (0.32) | GPR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1880986-B1 | PROCESS FOR PRODUCING SATURATED ALIPHATIC HYDROCARBONS, AND LUBRICANT COMPOSITIONS THEREOF | IDEMITSU KOSAN CO (JP) | 2013-03-06 | — | — | EP | disclosed |
| US-8373011-B2 | Used in a base oil of lubricant having good low temperature fluidity, low evaporativity, and thermal stability and oxidation stability | IDEMITSU KOSAN CO., LTD. (JP) | 2013-02-12 | — | — | US | disclosed |
| US-20080146469-A1 | Process for producing saturated aliphatic hydrocarbon compound, and lubricant composition | IDEMITSU KOSAN CO., LTD. (JP) | 2008-06-19 | — | — | US | disclosed |
| EP-1880986-A1 | PROCESS FOR PRODUCING SATURATED ALIPHATIC HYDROCARBON COMPOUND, AND LUBRICANT COMPOSITION | IDEMITSU KOSAN CO., LTD. (JP) | 2008-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080146469-A1 | Process for producing saturated aliphatic hydrocarbon compound, and lubricant composition | ALOX15, ALOX12, ALOX15B | GPR3 1117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.